R. K. Gupta

TL;DR: It is confirmed that elimination of cells bearing the Bcl-2/IgH rearrangement is highly desirable and should be attempted in patients with follicular lymphoma after high-dose therapy, and there is no survival advantage compared with conventional treatment.

TL;DR: The presence of circulating Bcl-2/IgH+ cells, other than those derived from the malignant clone, could confound the detection and quantitation of minimal residual disease in patients with FL, particularly at low levels of tumor burden.

TL;DR: This study shows the usefulness of coupling CGH, for detecting recurring abnormalities, with the real-time PCR technique for rapid gene dosage quantification and confirms that the REL gene is a potential candidate in the pathogenesis of a particular subset of follicular lymphomas.

TL;DR: Apart from possibly in the best-prognosis group, where results are equivalent, ChlVPP/EVA hybrid produces significantly better FFP, EFS, and OS than VAPEC-B in patients with previously untreated Hodgkin's disease.

TL;DR: The diffuse variant of LP-HD is rare, having not been seen at St. Bartholomew's Hospital during this time period and showed a favourable course with presentation at an early stage, good response to treatment, late recurrences and remission duration other than the other subtypes of HD.